Wart. Viral warts
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of plantar wart and common wart in the hands and feet
Exclusion criteria
Exclusion criteria: Patients with a history of formaldehyde allergy Immunodeficiency Severe dermatitis Diabetes Pregnancy or lactation History of respiratory illnesses such as asthma Any treatment for wart in the last two weeks Taking immunosuppressive drugs Any severe systemic disease Patients with peripheral vascular disorder Patients with peripheral neuropathy Patients who also have other skin conditions such as lichen planus, psoriasis or eczema in the site of wart lesions Inability to cooperate in using topical drugs due to young age or sensory impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wart count change. Timepoint: Before intervention and then every 4 weeks during intervention and three months after the end of the treatment. Method of measurement: By counting wart number. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dryness. Timepoint: Every 4 weeks during intervention. Method of measurement: Questionnaire.;Erythema. Timepoint: Every 4 weeks during intervention. Method of measurement: Questionnaire.;Fissuring. Timepoint: Every 4 weeks during intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences